By inhibiting FOXO3 activity, IPF lung fibroblasts maintain their pathological phenotype, characterized by enhanced proliferation, resistance to apoptosis, and excessive collagen matrix production, thereby promoting disease progression. Here, FOXO3 is linked to idiopathic pulmonary fibrosis.